To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry
出版年份 2018 全文链接
标题
To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry
作者
关键词
-
出版物
ANNALS OF THE RHEUMATIC DISEASES
Volume 78, Issue 2, Pages 192-200
出版商
BMJ
发表日期
2018-11-06
DOI
10.1136/annrheumdis-2018-213474
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Open-Label Non-Mandatory Transitioning From Originator Etanercept to Biosimilar SB4: 6-Month Results From a Controlled Cohort Study
- (2018) Lieke Tweehuysen et al. Arthritis & Rheumatology
- Biosimilars in rheumatology: A review of the evidence and their place in the treatment algorithm
- (2017) Hendrik Schulze-Koops et al. RHEUMATOLOGY
- Reviewing the evidence for biosimilars: key insights, lessons learned and future horizons
- (2017) Till Uhlig et al. RHEUMATOLOGY
- Assessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across Germany
- (2017) John Waller et al. Patient Preference and Adherence
- Switching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the Clinician
- (2017) Robert Moots et al. Current Rheumatology Reports
- Subjective Complaints as the Main Reason for Biosimilar Discontinuation After Open-Label Transition From Reference Infliximab to Biosimilar Infliximab
- (2017) Lieke Tweehuysen et al. Arthritis & Rheumatology
- Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians
- (2016) Hillel Cohen et al. ADVANCES IN THERAPY
- Difference between SB4 and reference etanercept in the hepatobiliary disorders not considered to be caused by SB4: response to letter by Scheinberg and Azevedo: Table 1
- (2016) Paul Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- The changing landscape of biosimilars in rheumatology
- (2016) Thomas Dörner et al. ANNALS OF THE RHEUMATIC DISEASES
- Generalizability of Patients With Rheumatoid Arthritis in Biologic Agent Clinical Trials
- (2016) Priyanka Vashisht et al. ARTHRITIS CARE & RESEARCH
- Patient attitudes and understanding about biosimilars: an international cross-sectional survey
- (2016) Ira Jacobs et al. Patient Preference and Adherence
- Pharmacoeconomics of Biosimilars: What Is There to Gain from Them?
- (2016) Filipe C. Araújo et al. Current Rheumatology Reports
- The Danish nationwide clinical register for patients with rheumatoid arthritis: DANBIO
- (2016) Else Helene Ibfelt et al. Clinical Epidemiology
- FRI0119 What Intrinsic and Extrinsic Factors Affect the Developement of Anti-Drug Antibody to Innovator Infliximab and its Biosimilar CT-P13 in Rheumatoid Arthritis and Ankylosing Spondylitis: Table 1.
- (2015) J. Braun et al. ANNALS OF THE RHEUMATIC DISEASES
- A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy
- (2015) Paul Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data
- (2015) Elena Nikiphorou et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Medicine's inconvenient truth: the placebo and nocebo effect
- (2014) M. H. Arnold et al. INTERNAL MEDICINE JOURNAL
- ECCO position statement: The use of biosimilar medicines in the treatment of inflammatory bowel disease (IBD)
- (2013) Silvio Danese et al. Journal of Crohns & Colitis
- The Danish National Patient Register
- (2011) Elsebeth Lynge et al. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
- European biologicals registers: methodology, selected results and perspectives
- (2008) A Zink et al. ANNALS OF THE RHEUMATIC DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started